Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5566 AL 5580

Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment

Modrego PJ.

J Alzheimers Dis. 2010;21(4):1077-87. doi: 10.3233/jad-2010-100153.

Oral health in Alzheimer's disease: a review

Mancini M, Grappasonni I, Scuri S, Amenta F.

Curr Alzheimer Res. 2010 Jun;7(4):368-73. doi: 10.2174/156720510791162359.

Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease

Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Gold M, Hopton G, Jacobs G, Davy M, Williams P.

Curr Alzheimer Res. 2010 Aug;7(5):374-85. doi: 10.2174/156720510791383831.

Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease

Kulkarni PV, Roney CA, Antich PP, Bonte FJ, Raghu AV, Aminabhavi TM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):35-47. doi: 10.1002/wnan.59.

An update on clinical proteomics in Alzheimer's research

Korolainen MA, Nyman TA, Aittokallio T, Pirttilä T.

J Neurochem. 2010 Mar;112(6):1386-414. doi: 10.1111/j.1471-4159.2009.06558.x. Epub 2009 Dec 24.

In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models

Higuchi M, Maeda J, Ji B, Maruyama M, Okauchi T, Tokunaga M, Ono M, Suhara T.

Biochim Biophys Acta. 2010 Apr;1802(4):373-88. doi: 10.1016/j.bbadis.2010.01.003. Epub 2010 Jan 12.

Neuropathologic alterations in mild cognitive impairment: a review

Markesbery WR.

J Alzheimers Dis. 2010;19(1):221-8. doi: 10.3233/JAD-2010-1220.

Neuroimaging through the course of Alzheimer's disease

Smith CD.

J Alzheimers Dis. 2010;19(1):273-90. doi: 10.3233/JAD-2010-1217.

Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy

McGeer EG, McGeer PL.

J Alzheimers Dis. 2010;19(1):355-61. doi: 10.3233/JAD-2010-1219.

Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: a meta-analysis

Mathias JL, Morphett K.

J Clin Exp Neuropsychol. 2010 Aug;32(7):682-98. doi: 10.1080/13803390903427414. Epub 2010 Jan 8.

Effects of aerobic exercise on mild cognitive impairment: a controlled trial

Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, Duncan GE, Mehta PD, Craft S.

Arch Neurol. 2010 Jan;67(1):71-9. doi: 10.1001/archneurol.2009.307.

Microwave accelerated synthesis of PET image contrast agents for AD research

Kallmerten AE, Jones GB.

Curr Alzheimer Res. 2010 May;7(3):251-4. doi: 10.2174/156720510791050830.

Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone

Valen-Sendstad A, Engedal K, Stray-Pedersen B; ADACT Study Group; Strobel C, Barnett L, Meyer N, Nurminemi M.

Am J Geriatr Psychiatry. 2010 Jan;18(1):11-20. doi: 10.1097/JGP.0b013e3181beaaf4.

Management of behavioral problems in Alzheimer's disease

Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C.

Int Psychogeriatr. 2010 May;22(3):346-72. doi: 10.1017/S1041610209991505. Epub 2010 Jan 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias